JP2017506923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506923A5 JP2017506923A5 JP2016543634A JP2016543634A JP2017506923A5 JP 2017506923 A5 JP2017506923 A5 JP 2017506923A5 JP 2016543634 A JP2016543634 A JP 2016543634A JP 2016543634 A JP2016543634 A JP 2016543634A JP 2017506923 A5 JP2017506923 A5 JP 2017506923A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- membrane
- nanofibril
- polysaccharide
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 75
- 239000012528 membrane Substances 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 10
- 210000000130 stem cell Anatomy 0.000 claims description 10
- 210000002950 fibroblast Anatomy 0.000 claims description 9
- 208000027418 Wounds and injury Diseases 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 210000000987 immune system Anatomy 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 210000002889 endothelial cell Anatomy 0.000 claims description 6
- 210000002510 keratinocyte Anatomy 0.000 claims description 6
- 206010052428 Wound Diseases 0.000 claims description 5
- 230000000735 allogeneic effect Effects 0.000 claims description 5
- 210000001608 connective tissue cell Anatomy 0.000 claims description 5
- 210000004443 dendritic cell Anatomy 0.000 claims description 5
- 210000002919 epithelial cell Anatomy 0.000 claims description 5
- 210000004700 fetal blood Anatomy 0.000 claims description 5
- 210000000442 hair follicle cell Anatomy 0.000 claims description 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 210000000663 muscle cell Anatomy 0.000 claims description 5
- 210000002569 neuron Anatomy 0.000 claims description 5
- 230000003169 placental effect Effects 0.000 claims description 5
- 239000002243 precursor Substances 0.000 claims description 5
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims description 5
- 210000002536 stromal cell Anatomy 0.000 claims description 5
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 230000004888 barrier function Effects 0.000 claims description 4
- 239000012867 bioactive agent Substances 0.000 claims description 4
- 210000002744 extracellular matrix Anatomy 0.000 claims description 4
- 210000001161 mammalian embryo Anatomy 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 108010067306 Fibronectins Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229940035676 analgesics Drugs 0.000 claims description 3
- 239000004037 angiogenesis inhibitor Substances 0.000 claims description 3
- 230000002491 angiogenic effect Effects 0.000 claims description 3
- 239000000730 antalgic agent Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 230000000843 anti-fungal effect Effects 0.000 claims description 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 230000000840 anti-viral effect Effects 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 239000000739 antihistaminic agent Substances 0.000 claims description 3
- 229940125715 antihistaminic agent Drugs 0.000 claims description 3
- -1 antiviral compounds Chemical class 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 108010015046 cell aggregation factors Proteins 0.000 claims description 3
- 230000024245 cell differentiation Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 229960001438 immunostimulant agent Drugs 0.000 claims description 3
- 239000003022 immunostimulating agent Substances 0.000 claims description 3
- 230000003308 immunostimulating effect Effects 0.000 claims description 3
- 239000002858 neurotransmitter agent Substances 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 230000002188 osteogenic effect Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 102000012422 Collagen Type I Human genes 0.000 claims description 2
- 108010022452 Collagen Type I Proteins 0.000 claims description 2
- 102000000503 Collagen Type II Human genes 0.000 claims description 2
- 108010041390 Collagen Type II Proteins 0.000 claims description 2
- 102000004266 Collagen Type IV Human genes 0.000 claims description 2
- 108010042086 Collagen Type IV Proteins 0.000 claims description 2
- 102000007547 Laminin Human genes 0.000 claims description 2
- 108010085895 Laminin Proteins 0.000 claims description 2
- 108010031318 Vitronectin Proteins 0.000 claims description 2
- 102100035140 Vitronectin Human genes 0.000 claims description 2
- 229940035674 anesthetics Drugs 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 238000002059 diagnostic imaging Methods 0.000 claims description 2
- 239000003193 general anesthetic agent Substances 0.000 claims description 2
- 239000012216 imaging agent Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims 11
- 150000004676 glycans Chemical class 0.000 claims 10
- 229920001282 polysaccharide Polymers 0.000 claims 10
- 239000005017 polysaccharide Substances 0.000 claims 10
- 239000012736 aqueous medium Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 210000003321 cartilage cell Anatomy 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229920002101 Chitin Polymers 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 229920002488 Hemicellulose Polymers 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 claims 1
- 239000012790 adhesive layer Substances 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000617 arabinoxylan Polymers 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 230000003232 mucoadhesive effect Effects 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 229920001277 pectin Polymers 0.000 claims 1
- 239000001814 pectin Substances 0.000 claims 1
- 235000010987 pectin Nutrition 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 230000036573 scar formation Effects 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000008223 sterile water Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 208000037816 tissue injury Diseases 0.000 claims 1
- 102100029647 Apoptosis-associated speck-like protein containing a CARD Human genes 0.000 description 7
- 101000728679 Homo sapiens Apoptosis-associated speck-like protein containing a CARD Proteins 0.000 description 7
- 239000004744 fabric Substances 0.000 description 6
- 231100000241 scar Toxicity 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 5
- 238000001878 scanning electron micrograph Methods 0.000 description 5
- 208000032544 Cicatrix Diseases 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 229920001046 Nanocellulose Polymers 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 230000037387 scars Effects 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 210000001612 chondrocyte Anatomy 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 102000016359 Fibronectins Human genes 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20136336 | 2013-12-30 | ||
| FI20136336A FI126854B (en) | 2013-12-30 | 2013-12-30 | The membrane, its use and the method for making the membrane |
| PCT/FI2014/051062 WO2015101712A1 (en) | 2013-12-30 | 2014-12-30 | Biomedical device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017506923A JP2017506923A (ja) | 2017-03-16 |
| JP2017506923A5 true JP2017506923A5 (enExample) | 2019-12-26 |
| JP6636926B2 JP6636926B2 (ja) | 2020-01-29 |
Family
ID=52347346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016543634A Active JP6636926B2 (ja) | 2013-12-30 | 2014-12-30 | 生体医学的装置 |
| JP2016543668A Active JP6576933B2 (ja) | 2013-12-30 | 2014-12-30 | パターニングされたメンブレン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016543668A Active JP6576933B2 (ja) | 2013-12-30 | 2014-12-30 | パターニングされたメンブレン |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20160325006A1 (enExample) |
| EP (2) | EP3089764A1 (enExample) |
| JP (2) | JP6636926B2 (enExample) |
| CN (2) | CN106132447A (enExample) |
| DK (1) | DK3089765T3 (enExample) |
| FI (1) | FI126854B (enExample) |
| WO (2) | WO2015101712A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2706489T3 (es) * | 2015-12-31 | 2019-03-29 | Upm Kymmene Corp | Un producto médico de multi-capa que comprende celulosa nanofibrilar y un método de preparación del mismo |
| EP3228329B1 (en) * | 2016-04-06 | 2022-06-08 | UPM-Kymmene Corporation | A method for preparing a medical product comprising nanofibrillar cellulose and a medical product |
| WO2017214592A1 (en) * | 2016-06-09 | 2017-12-14 | Paul Gatenholm | Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks |
| JP6139754B1 (ja) * | 2016-06-17 | 2017-05-31 | 株式会社ユーグレナ | 細胞増殖促進剤 |
| FI127590B (en) | 2016-07-04 | 2018-09-28 | Teknologian Tutkimuskeskus Vtt Oy | Cellulose-based membrane structure and process for making one |
| WO2018074432A1 (ja) * | 2016-10-17 | 2018-04-26 | 株式会社日本触媒 | 細胞培養用基材およびその製造方法、ならびにこれを利用した細胞培養容器および細胞培養方法 |
| EP3335695B1 (en) * | 2016-12-15 | 2020-02-05 | UPM-Kymmene Corporation | A method for freeze-drying hydrogel comprising nanofibrillar cellulose, a freeze-dried medical hydrogel comprising nanofibrillar cellulose, and a hydrogel comprising nanofibrillar cellulose |
| JP6907601B2 (ja) * | 2017-03-02 | 2021-07-21 | 王子ホールディングス株式会社 | 積層シート |
| JP6866693B2 (ja) * | 2017-03-02 | 2021-04-28 | 王子ホールディングス株式会社 | シート |
| WO2018165327A1 (en) | 2017-03-08 | 2018-09-13 | Alafair Biosciences, Inc. | Hydrogel medium for the storage and preservation of tissue |
| WO2019010570A1 (en) * | 2017-07-10 | 2019-01-17 | The Governors Of The University Of Alberta | PATTERNED MICROFILTER MEMBRANE AND PREPARATION METHOD THEREOF |
| CN109381742B (zh) * | 2017-08-09 | 2022-05-03 | 国家纳米科学中心 | 基于图案化细菌纤维素的三维人工椎间盘及其制备方法和应用 |
| CN107638587A (zh) * | 2017-09-25 | 2018-01-30 | 凯斯蒂南京医疗器械有限公司 | 具有组织诱导功能的无疤痕再生医用敷料及其制备方法 |
| WO2019145795A2 (en) | 2018-01-26 | 2019-08-01 | Cellink Ab | Systems and methods for optical assessments of bioink printability |
| US11186736B2 (en) | 2018-10-10 | 2021-11-30 | Cellink Ab | Double network bioinks |
| US11826951B2 (en) | 2019-09-06 | 2023-11-28 | Cellink Ab | Temperature-controlled multi-material overprinting |
| EP3791864A1 (en) * | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Method for preparing pharmaceutical composition and pharmaceutical composition |
| ES2999324T3 (en) * | 2019-10-31 | 2025-02-25 | Upm Kymmene Corp | Medical product and method for preparing thereof |
| SE544449C2 (en) * | 2019-12-23 | 2022-05-31 | Stora Enso Oyj | Method for manufacture of a patterned liquid repellent nanocellulosic film |
| CN111265709A (zh) * | 2020-03-20 | 2020-06-12 | 陈传华 | 一种儿科用防止肺炎病毒感染的伤口防护膜及其制备方法 |
| US20230310699A1 (en) * | 2020-06-10 | 2023-10-05 | The Australian National University | Haemostatic material |
| CN113249294B (zh) * | 2021-05-17 | 2022-09-27 | 北京化工大学 | 一种能够使细胞图案化生长的表面及其应用 |
| CN113952114B (zh) * | 2021-09-24 | 2022-09-09 | 北京科技大学 | 具有图案化可释放气体的多层纳米纤维敷料及其制备方法 |
| CN114848898B (zh) * | 2022-06-23 | 2023-07-21 | 点云生物(杭州)有限公司 | 一种基于3d打印工艺制造的人工骨支架及方法 |
| US20240091399A1 (en) * | 2022-09-09 | 2024-03-21 | Upm-Kymmene Corporation | Medical grade nanofibrillar cellulose hydrogel, a method for treating a subject in need of treatment of body with implantable material and a method for manufacturing the medical grade nanofibrillar cellulose hydrogel |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602994B1 (en) * | 1999-02-10 | 2003-08-05 | Hercules Incorporated | Derivatized microfibrillar polysaccharide |
| AU6072200A (en) | 1999-07-09 | 2001-01-30 | Advanced Tissue Sciences, Inc. | Human naturally secreted extracellular matrix-coated device |
| US6202994B1 (en) * | 1999-11-23 | 2001-03-20 | William Spurlin | High energy spring for vibratory devices |
| US8277837B2 (en) * | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
| US8728817B2 (en) * | 2007-05-04 | 2014-05-20 | University Of Virginia Patent Foundation | Compositions and methods for making and using laminin nanofibers |
| EP2365832A2 (en) * | 2008-11-07 | 2011-09-21 | Sofradim Production | Template for bacterial cellulose implant processed within bioreactor |
| US20100158985A1 (en) * | 2008-12-19 | 2010-06-24 | Xylos Corporation | Porous structures of microbial-derived cellulose for in vivo implantation |
| FI123988B (fi) * | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Soluviljelymateriaali |
| US8906393B2 (en) * | 2011-01-26 | 2014-12-09 | Rutgers, The State University Of New Jersey | Biofilm inhibiting composition |
| EP3719192B1 (en) * | 2012-01-04 | 2025-06-25 | The Procter & Gamble Company | Fibrous structures comprising particles and methods for making same |
| FI126055B (en) * | 2012-05-14 | 2016-06-15 | Upm Kymmene Corp | A method of making a film from fibril pulp and a fibril pulp film |
-
2013
- 2013-12-30 FI FI20136336A patent/FI126854B/en active IP Right Grant
-
2014
- 2014-12-30 EP EP14827247.9A patent/EP3089764A1/en not_active Withdrawn
- 2014-12-30 JP JP2016543634A patent/JP6636926B2/ja active Active
- 2014-12-30 CN CN201480071650.3A patent/CN106132447A/zh active Pending
- 2014-12-30 CN CN201480071655.6A patent/CN105873621A/zh active Pending
- 2014-12-30 US US15/109,068 patent/US20160325006A1/en not_active Abandoned
- 2014-12-30 DK DK14828042.3T patent/DK3089765T3/da active
- 2014-12-30 WO PCT/FI2014/051062 patent/WO2015101712A1/en not_active Ceased
- 2014-12-30 US US15/108,943 patent/US20160325008A1/en not_active Abandoned
- 2014-12-30 JP JP2016543668A patent/JP6576933B2/ja active Active
- 2014-12-30 EP EP14828042.3A patent/EP3089765B1/en active Active
- 2014-12-30 WO PCT/FI2014/051061 patent/WO2015101711A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | Biomimetic asymmetric composite dressing by electrospinning with aligned nanofibrous and micropatterned structures for severe burn wound healing | |
| Liu et al. | Promotion of wound healing using nanoporous silk fibroin sponges | |
| Lu et al. | Anisotropic biomimetic silk scaffolds for improved cell migration and healing of skin wounds | |
| Goodarzi et al. | Tissue engineered skin substitutes | |
| Sun et al. | Neurotrophin-3-loaded multichannel nanofibrous scaffolds promoted anti-inflammation, neuronal differentiation, and functional recovery after spinal cord injury | |
| Lashkari et al. | Cell-based wound dressing: Bilayered PCL/gelatin nanofibers-alginate/collagen hydrogel scaffold loaded with mesenchymal stem cells | |
| CN105339018B (zh) | 组织修复支架及其制备方法和用途 | |
| Li et al. | Controlling the multiscale network structure of fibers to stimulate wound matrix rebuilding by fibroblast differentiation | |
| JP6636926B2 (ja) | 生体医学的装置 | |
| Yang et al. | N-cadherin-functionalized nanofiber hydrogel facilitates spinal cord injury repair by building a favorable niche for neural stem cells | |
| US20110008397A1 (en) | Compartmental extract compositions for tissue engineering | |
| Datta et al. | Oleoyl-chitosan-based nanofiber mats impregnated with amniotic membrane derived stem cells for accelerated full-thickness excisional wound healing | |
| Liu et al. | Synthetic nanofiber-reinforced amniotic membrane via interfacial bonding | |
| Kong et al. | Melt electrowriting (MEW)-PCL composite three-dimensional exosome hydrogel scaffold for wound healing | |
| US20230293450A1 (en) | Fibrous composite material | |
| CN104248777A (zh) | 组织修复支架、其制备方法和用途 | |
| Wu et al. | Production of chitosan scaffolds by lyophilization or electrospinning: which is better for peripheral nerve regeneration? | |
| Gholipour-Kanani et al. | Effect of tissue-engineered chitosan-poly (vinyl alcohol) nanofibrous scaffolds on healing of burn wounds of rat skin | |
| CN107496972B (zh) | 一种促烧伤创面愈合的防粘连湿性敷料及其制备方法 | |
| Prakashan et al. | Bone marrow derived mesenchymal stem cells enriched PCL-gelatin nanofiber scaffold for improved wound healing | |
| JPWO2019208688A1 (ja) | 生体移植用細胞シート及びその製造方法 | |
| Zhou et al. | Multifunctional nanofiber-based dressings in coordination with adipose-derived stem cells for accelerated burn wound healing | |
| Wen et al. | Multifunctional nanofiber membranes constructed by microfluidic blow-spinning to inhibit scar formation at early intervention stage | |
| Tekinay et al. | Stem Cells and Nanofibers for Skin Regeneration and Wound Healing | |
| US20240307591A1 (en) | Accelerated Development of Functional Three-Dimensional Tissue Moduli |